In contrast to the expression levels of TGF-β1, there was lower UCP3 expression in DCM hearts from metoprolol-treated patients as compared to those who had not received metoprolol (Fig. 7B). The gene discussed is TGFB1; the disease is familial dilated cardiomyopathy.